Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Investigations in Gynecology Research & Womens Health

Effects of KRAS Gene Mutations in Gynaecological Malignancies

  • Open or Close Keerthana S1, Akram Husain RS2 and Ramakrishnan V2*

    1Medical Genetics and Molecular Diagnostics, Faculty of Allied Health Sciences, India

    2Genetics Lab, Faculty of Allied Health Sciences, India

    *Corresponding author: Ramakrishnan V, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam - 603 103, India, Email: rkgenes@gmail.com

Submission: April 07, 2018;Published: May 08, 2018

DOI: 10.31031/IGRWH.2018.02.000531

ISSN: 2577-2015
Volume2 Issue1

Abstract

Gynaecological disorders and malignancies affect the female reproductive system. Every woman in her life time suffers from gynaecological problem at some extent. The development and pathogenesis of gynaecological disorders is still remains unclear, several clinical and epidemiological studies have documented that they can be triggered by environmental, life-style, genetic factors and epigenetic alterations.The KRAS (Kristen rat sarcoma viral oncogene) gene is the commonly mutated oncogene. This gene provides instructions for making a protein called as K-Ras, which plays a vital role in cell division, differentiation and apoptosis. The frequency of mutations in this oncogene is highly reported in gynaecological cancers. This review highlights the common mutations observed in KRAS gene that is associated with breast, cervical, ovarian and endometrial cancer. These genetic variations can be considered with their clinical significance and might be used as diagnostic biomarkers and testing for RAS pathway mutations.

Keywords: KRAS; Mutation; Gynaecological malignancies; Breast cancer; Cervical cancer

Get access to the full text of this article